Crossmark

Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA

Crossref DOI link: https://doi.org/10.4143/crt.2018.070

Published Print: 2019-01-15

Update policy: https://doi.org/10.4143/crossmark_policy

Authors

Xue, Ning

Lin, Jian-Hua

Xing, Shan

Liu, Dan

Li, Shi-Bing

Lai, Yan-Zhen

Wang, Xue-Ping

Mao, Min-Jie

Zhong, Qian

Zeng, Mu-Sheng

Liu, Wan-Li
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81472008, 81271902)
License Information

Text and Data Mining valid from 2018-05-29
More Information

Publication History

Received: 2018-01-29

Accepted: 2018-05-28

Published online: 2018-05-29

Print publication: 2019-01-15

Document is current

Any future updates will be listed below